Eri Takano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eri Takano has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Toshifumi Takeuchi
Center for Advanced Medical Engineering Rsearch & Development (CAMED) Kobe University 1‐1 Rokkodai‐cho Nada‐ku Kobe 657–8501 Japan
21 shared publications - Yukiya Kitayama
Department of Applied Chemistry, Graduate School of Engineering, Osaka Metropolitan University, 1-1, Gakuen-cho, Naka-ku, Sakai, Osaka 599-8531, Japan
17 shared publications - Hirobumi Sunayama
Graduate School of Engineering, Kobe University, 1-1, Rokkodai-cho, Nada-ku, Kobe 657-8501, Japan
13 shared publications - Ryohei Sasaki
Division of Radiation Oncology, Kobe University Graduate School of Medicine, Kobe, Japan
3 shared publications - Tooru Ooya
Department of Chemical Science and Engineering, Graduate School of Engineering, Kobe University, Kobe, Japan
3 shared publications Akane Uchida
Graduate School of Engineering, Kobe University , 1-1 Rokkodai-cho, Nada-ku, Kobe 657-8501, Japan
2 shared publications
Latest Publications
- Open Access
- 24 August 2023
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 15 (37) , 15171-15178
A rapid abiotic/biotic hybrid sandwich detection for trace pork adulteration in halal meat extract
A novel sandwich detection was demonstrated for 0.01 wt% pork adulteration within 30 min, using PSA-imprinted polymer nanogels to capture PSA and anti-PSA antibody complexed with-Fc-domain imprinted fluorescent polymer nanogels to detect PSA.
- 24 August 2023
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 15 (37) , 15171-15178
Open AccessA rapid abiotic/biotic hybrid sandwich detection for trace pork adulteration in halal meat extract
A novel sandwich detection was demonstrated for 0.01 wt% pork adulteration within 30 min, using PSA-imprinted polymer nanogels to capture PSA and anti-PSA antibody complexed with-Fc-domain imprinted fluorescent polymer nanogels to detect PSA.
- 27 May 2022
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 10 (35) , 6784-6791
In vivo stealthified molecularly imprinted polymer nanogels incorporated with gold nanoparticles for radiation therapy
Gold-nanoparticle-incorporated molecularly imprinted nanogels acquire stealth capabilities in vivo through protein corona regulation using intrinsic dysopsonic proteins. The composite can be used in radiation therapy to treat mouse pancreatic cancer.
- 27 May 2022
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 10 (35) , 6784-6791
In vivo stealthified molecularly imprinted polymer nanogels incorporated with gold nanoparticles for radiation therapy
Gold-nanoparticle-incorporated molecularly imprinted nanogels acquire stealth capabilities in vivo through protein corona regulation using intrinsic dysopsonic proteins. The composite can be used in radiation therapy to treat mouse pancreatic cancer.
- 14 April 2022
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 10 (10) , 2665-2672
Biocompatible polymer-modified gold nanocomposites of different shapes as radiation sensitizers
Biocompatible polymer-modified gold nanocomposites of different shapes (nanoparticles, rods, and stars) were created to serve as radiation sensitizers. The therapeutic effect of the radiated nanostars proved to be the most effective.
- 14 April 2022
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 10 (10) , 2665-2672
Biocompatible polymer-modified gold nanocomposites of different shapes as radiation sensitizers
Biocompatible polymer-modified gold nanocomposites of different shapes (nanoparticles, rods, and stars) were created to serve as radiation sensitizers. The therapeutic effect of the radiated nanostars proved to be the most effective.
- Open Access
- 8 February 2021
- Published by Wiley in Advanced NanoBiomed Research
- Vol. 1 (4) , 2000079
Fluorescent Signaling of Molecularly Imprinted Nanogels Prepared via Postimprinting Modifications for Specific Protein Detection
Previous reports have stated the advantages of postimprinting modification (PIM) to develop multifunctional molecularly imprinted polymers (MIPs). However, existing technologies have only been applied on bulk‐ and film‐based MIPs. Herein, the fluorescent signaling of nanogels (NGs) for protein detection is demonstrated. The NGs are prepared by molecular imprinting and PIM. A bivalent functional monomer, 4‐[2‐(N‐methacrylamido)ethylaminomethyl] benzoic acid (FM1), comprising a benzoic acid moiety for interaction with proteins and secondary amine group for incorporating fluorescent reporter molecules is used. Human serum albumin (HSA), a marker protein for human health, serves as the model protein. HSA‐imprinted NGs (MIP‐NGs) are prepared by emulsifier‐free precipitation polymerization of FM1, N‐isopropylacrylamide, 2‐methacryloxyethyl phosphorylcholine, and N,N′‐methylenebis acrylamide in the presence of HSA. After the removal of HSA, a fluorescent dye (ATTO 647 N) is treated with amino groups on FM1 residue as the PIM; this yields fluorescent‐signaling MIP‐NGs (FL‐MIP‐NGs) of ≈20 nm in diameter. The FL‐MIP‐NG‐based sensing system detects HSA in a real sample by selectively reading out the HSA‐binding events as high‐affinity fluorescence changes (Kd = 2.5 × 10−9 M). The proposed MIP‐NGs functionalized via PIMs serve as advanced functional materials for sensing biorelated compounds.
- 8 February 2021
- Published by Wiley in Advanced NanoBiomed Research
- Vol. 1 (4) , 2000079
Open AccessFluorescent Signaling of Molecularly Imprinted Nanogels Prepared via Postimprinting Modifications for Specific Protein Detection
Previous reports have stated the advantages of postimprinting modification (PIM) to develop multifunctional molecularly imprinted polymers (MIPs). However, existing technologies have only been applied on bulk‐ and film‐based MIPs. Herein, the fluorescent signaling of nanogels (NGs) for protein detection is demonstrated. The NGs are prepared by molecular imprinting and PIM. A bivalent functional monomer, 4‐[2‐(N‐methacrylamido)ethylaminomethyl] benzoic acid (FM1), comprising a benzoic acid moiety for interaction with proteins and secondary amine group for incorporating fluorescent reporter molecules is used. Human serum albumin (HSA), a marker protein for human health, serves as the model protein. HSA‐imprinted NGs (MIP‐NGs) are prepared by emulsifier‐free precipitation polymerization of FM1, N‐isopropylacrylamide, 2‐methacryloxyethyl phosphorylcholine, and N,N′‐methylenebis acrylamide in the presence of HSA. After the removal of HSA, a fluorescent dye (ATTO 647 N) is treated with amino groups on FM1 residue as the PIM; this yields fluorescent‐signaling MIP‐NGs (FL‐MIP‐NGs) of ≈20 nm in diameter. The FL‐MIP‐NG‐based sensing system detects HSA in a real sample by selectively reading out the HSA‐binding events as high‐affinity fluorescence changes (Kd = 2.5 × 10−9 M). The proposed MIP‐NGs functionalized via PIMs serve as advanced functional materials for sensing biorelated compounds.
- 10 March 2020
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 142 (14) , 6617-6624
Antibody-Conjugated Signaling Nanocavities Fabricated by Dynamic Molding for Detecting Cancers Using Small Extracellular Vesicle Markers from Tears
Small extracellular vesicles (sEVs) are reliable biomarkers for early cancer detection; however, conventional detection methods such as immune-based assays and microRNA analyses are not very sensitive and require sample pre-treatments and long analysis time. Here, we developed a molecular imprinting-based dynamic molding approach to fabricate antibody-conjugated signaling nanocavities capable of size recognition. This enabled the establishment of an easy-to-use, rapid, sensitive, pre-treatment-free, and non-invasive sEV detection platform for efficient sEV detection-based cancer diagnosis. An apparent dissociation constant was estimated to be 2.4 × 10-16 M, which was ~1,000 times higher than that of commercial immunoassays (analysis time, 5 min/sample). We successfully used tears for the first time to detect cancer-related intact sEVs, clearly differentiating between healthy donors and breast cancer patients, as well as between samples collected before and after total mastectomy. Our nanoprocessing strategy can be easily repurposed for the specific detection of other types of cancer by changing the conjugated anti-bodies, thereby facilitating the establishment of liquid biopsy for early cancer diagnosis.
- 10 March 2020
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 142 (14) , 6617-6624
Antibody-Conjugated Signaling Nanocavities Fabricated by Dynamic Molding for Detecting Cancers Using Small Extracellular Vesicle Markers from Tears
Small extracellular vesicles (sEVs) are reliable biomarkers for early cancer detection; however, conventional detection methods such as immune-based assays and microRNA analyses are not very sensitive and require sample pre-treatments and long analysis time. Here, we developed a molecular imprinting-based dynamic molding approach to fabricate antibody-conjugated signaling nanocavities capable of size recognition. This enabled the establishment of an easy-to-use, rapid, sensitive, pre-treatment-free, and non-invasive sEV detection platform for efficient sEV detection-based cancer diagnosis. An apparent dissociation constant was estimated to be 2.4 × 10-16 M, which was ~1,000 times higher than that of commercial immunoassays (analysis time, 5 min/sample). We successfully used tears for the first time to detect cancer-related intact sEVs, clearly differentiating between healthy donors and breast cancer patients, as well as between samples collected before and after total mastectomy. Our nanoprocessing strategy can be easily repurposed for the specific detection of other types of cancer by changing the conjugated anti-bodies, thereby facilitating the establishment of liquid biopsy for early cancer diagnosis.
- Open Access
- 20 February 2019
- Published by Taylor & Francis in Science and Technology of Advanced Materials
- Vol. 20 (1) , 305-312
Site-specific post-imprinting modification of molecularly imprinted polymer nanocavities with a modifiable functional monomer for prostate cancer biomarker recognition
Recognition of glycans of glycoproteins using biotic materials such as antibodies is challenging due to lack of antigenicity. Polymeric materials suitable for the molecular recognition of glycoproteins have attracted considerable attention. In this study, we aimed to develop abiotic molecular materials for the recognition of prostate-specific antigen (PSA), a known biomarker for prostate cancer. We used a non-covalent bonding-based molecular imprinting technique to introduce post-imprinting poly(ethylene glycol)-based capping agent into a low-affinity recognition cavity. Details of the binding properties of these groups were investigated to optimize their affinity and selectivity for PSA. Molecularly imprinted polymers (MIPs) were prepared using a bottom-up approach based on surface-initiated atom transfer radical polymerization from a PSA-conjugated sensor chip with a functional monomer-bearing carboxy and secondary amine groups as interaction and post-imprinting modification (PIM) sites, respectively. PSA was orientationally conjugated on the sensor chip through diesters between the immobilized 3-fluorophenyl boronic acid and the cis-diol groups of PSA glucans. Treatment with the capping agent selectively inactivated low-affinity recognition cavities while protecting high-affinity cavities with the addition of a low concentration of PSA as a dynamic protection agent. The MIP thickness is critical in the present molecular imprinting, as a value of less than 5 nm can enable high selectivity. We believe that the proposed strategy based on a non-covalent molecular imprinting approach combined with a PIM-based capping treatment provides a novel method for the development of highly sensitive and selective glycoprotein recognition materials for use in biomarker sensing. Graphical abstract
- 20 February 2019
- Published by Taylor & Francis in Science and Technology of Advanced Materials
- Vol. 20 (1) , 305-312
Open AccessSite-specific post-imprinting modification of molecularly imprinted polymer nanocavities with a modifiable functional monomer for prostate cancer biomarker recognition
Recognition of glycans of glycoproteins using biotic materials such as antibodies is challenging due to lack of antigenicity. Polymeric materials suitable for the molecular recognition of glycoproteins have attracted considerable attention. In this study, we aimed to develop abiotic molecular materials for the recognition of prostate-specific antigen (PSA), a known biomarker for prostate cancer. We used a non-covalent bonding-based molecular imprinting technique to introduce post-imprinting poly(ethylene glycol)-based capping agent into a low-affinity recognition cavity. Details of the binding properties of these groups were investigated to optimize their affinity and selectivity for PSA. Molecularly imprinted polymers (MIPs) were prepared using a bottom-up approach based on surface-initiated atom transfer radical polymerization from a PSA-conjugated sensor chip with a functional monomer-bearing carboxy and secondary amine groups as interaction and post-imprinting modification (PIM) sites, respectively. PSA was orientationally conjugated on the sensor chip through diesters between the immobilized 3-fluorophenyl boronic acid and the cis-diol groups of PSA glucans. Treatment with the capping agent selectively inactivated low-affinity recognition cavities while protecting high-affinity cavities with the addition of a low concentration of PSA as a dynamic protection agent. The MIP thickness is critical in the present molecular imprinting, as a value of less than 5 nm can enable high selectivity. We believe that the proposed strategy based on a non-covalent molecular imprinting approach combined with a PIM-based capping treatment provides a novel method for the development of highly sensitive and selective glycoprotein recognition materials for use in biomarker sensing. Graphical abstract
- Open Access
- 16 January 2019
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 4 (1) , 1487-1493
Highly Sensitive Fluoro-Immunosensing for Biomarker Detection Using an Automatic Pipette Tip-Type Biosensing System
An automatic fluorescence detection system based on a pipette tip-type biosensor was developed to detect a prostate-specific antigen (PSA), a biomarker for prostate cancer. Fluorescence-based immunosensing for PSA detection was performed by a sandwich assay with a fluorescence-labeled antibody or its fragments. A small protein A-immobilized reaction plate was placed on a plastic pipette tip (referred to as a Biologi tip). For automatic PSA detection, a programmable dispensing robot equipped with a photodetector was used to suction the samples (i.e., capture antibody, antigen, primary antibody, and reporter molecule), incubation, and migration of the pipette tip to the detection port to measure fluorescence. The use of Fab-fragments and F(ab′)2-fragments as fluorescently labeled detection antibodies in a sandwich assay resulted in higher signal-to-noise ratios than those for whole IgG. The PSA detection in normal human serum using an Alexa Fluor 647-labeled F(ab′)2-fragment secondary antibody showed that the fluorescence intensity increased proportionally with PSA concentration, with an estimated detection limit of 1.2 ng/mL. Moreover, 10 pg/mL PSA was detected using an enzymatic reaction with a peroxidase-conjugated F(ab′)2-fragment secondary antibody and Amplex Red as a substrate. These data indicate that this system is capable of highly sensitive fluorescence-based detection of PSA and suggests the potential for early diagnosis of disease or applications with other biomarkers.
- 16 January 2019
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 4 (1) , 1487-1493
Open AccessHighly Sensitive Fluoro-Immunosensing for Biomarker Detection Using an Automatic Pipette Tip-Type Biosensing System
An automatic fluorescence detection system based on a pipette tip-type biosensor was developed to detect a prostate-specific antigen (PSA), a biomarker for prostate cancer. Fluorescence-based immunosensing for PSA detection was performed by a sandwich assay with a fluorescence-labeled antibody or its fragments. A small protein A-immobilized reaction plate was placed on a plastic pipette tip (referred to as a Biologi tip). For automatic PSA detection, a programmable dispensing robot equipped with a photodetector was used to suction the samples (i.e., capture antibody, antigen, primary antibody, and reporter molecule), incubation, and migration of the pipette tip to the detection port to measure fluorescence. The use of Fab-fragments and F(ab′)2-fragments as fluorescently labeled detection antibodies in a sandwich assay resulted in higher signal-to-noise ratios than those for whole IgG. The PSA detection in normal human serum using an Alexa Fluor 647-labeled F(ab′)2-fragment secondary antibody showed that the fluorescence intensity increased proportionally with PSA concentration, with an estimated detection limit of 1.2 ng/mL. Moreover, 10 pg/mL PSA was detected using an enzymatic reaction with a peroxidase-conjugated F(ab′)2-fragment secondary antibody and Amplex Red as a substrate. These data indicate that this system is capable of highly sensitive fluorescence-based detection of PSA and suggests the potential for early diagnosis of disease or applications with other biomarkers.
- 4 December 2018
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 58 (6) , 1612-1615
A Pretreatment‐Free, Polymer‐Based Platform Prepared by Molecular Imprinting and Post‐Imprinting Modifications for Sensing Intact Exosomes
Exosomes are small (30–100 nm) membrane vesicles that serve as regulatory agents for intercellular communication in cancers. Currently, exosomes are detected by immuno‐based assays with appropriate pretreatments like ultracentrifugation and are time consuming (>12 h). We present a novel pretreatment‐free fluorescence‐based sensing platform for intact exosomes, wherein exchangeable antibodies and fluorescent reporter molecules were aligned inside exosome‐binding cavities. Such antibody‐containing fluorescent reporter‐grafted nanocavities were prepared on a substrate by well‐designed molecular imprinting and post‐imprinting modifications to introduce antibodies and fluorescent reporter molecules only inside the binding nanocavities, enabling sufficiently high sensitivity to detect intact exosomes without pretreatment. The effectiveness of the system was demonstrated by using it to discriminate between normal exosomes and those originating from prostate cancer and analyze exosomes in tear drops.
- 4 December 2018
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 58 (6) , 1612-1615
A Pretreatment‐Free, Polymer‐Based Platform Prepared by Molecular Imprinting and Post‐Imprinting Modifications for Sensing Intact Exosomes
Exosomes are small (30–100 nm) membrane vesicles that serve as regulatory agents for intercellular communication in cancers. Currently, exosomes are detected by immuno‐based assays with appropriate pretreatments like ultracentrifugation and are time consuming (>12 h). We present a novel pretreatment‐free fluorescence‐based sensing platform for intact exosomes, wherein exchangeable antibodies and fluorescent reporter molecules were aligned inside exosome‐binding cavities. Such antibody‐containing fluorescent reporter‐grafted nanocavities were prepared on a substrate by well‐designed molecular imprinting and post‐imprinting modifications to introduce antibodies and fluorescent reporter molecules only inside the binding nanocavities, enabling sufficiently high sensitivity to detect intact exosomes without pretreatment. The effectiveness of the system was demonstrated by using it to discriminate between normal exosomes and those originating from prostate cancer and analyze exosomes in tear drops.
- 4 December 2018
- Published by Wiley in Chemnanomat
- Vol. 5 (2) , 224-229
Post‐Imprinting‐Modified Molecularly Imprinted Nanocavities with Two Synergetic, Orthogonal, Glycoprotein‐Binding Sites to Transduce Binding Events into Fluorescence Changes
We developed sensitive and selective polymeric nanocavities for glycoprotein detection using a novel molecular imprinting technique involving post‐imprinting modification (PIM). It allowed the introduction of two different interaction sites and a fluorescent reporter within each nanocavity. The hepatocellular carcinoma biomarker α‐fetoprotein (AFP) was used as a model glycoprotein. For PIM‐based molecular imprinting, AFP conjugated with polymerizable groups by disulfide bonding was prepared and immobilized on a 4‐carboxy‐3‐fluorophenylboronic acid‐immobilized substrate by cyclic diester formation between AFP glycans in an oriented immobilization manner, facilitating the creation of homogeneous AFP‐imprinted nanocavities. Surface‐initiated controlled/living radical polymerization was performed with a functional monomer, co‐monomer, and crosslinker. The disulfide bonds and cyclic diesters were cleaved to create AFP‐imprinted nanocavities, generating free thiol groups present inside the nanocavities only. A thiol‐reactive fluorescent dye was added to the nanocavities by in‐cavity PIM, yielding signaling AFP‐imprinted nanocavities capable of transducing AFP‐binding events into fluorescence changes. Reference proteins showed little response, while the limit of detection of AFP was 0.27 ng/mL (ca. 3.9 pM) in diluted human serum. Thus, the proposed in‐cavity PIM‐based molecular imprinting technique is effective for ELISA‐relevant, antibody‐free sensing systems for glycoproteins.
- 4 December 2018
- Published by Wiley in Chemnanomat
- Vol. 5 (2) , 224-229
Post‐Imprinting‐Modified Molecularly Imprinted Nanocavities with Two Synergetic, Orthogonal, Glycoprotein‐Binding Sites to Transduce Binding Events into Fluorescence Changes
We developed sensitive and selective polymeric nanocavities for glycoprotein detection using a novel molecular imprinting technique involving post‐imprinting modification (PIM). It allowed the introduction of two different interaction sites and a fluorescent reporter within each nanocavity. The hepatocellular carcinoma biomarker α‐fetoprotein (AFP) was used as a model glycoprotein. For PIM‐based molecular imprinting, AFP conjugated with polymerizable groups by disulfide bonding was prepared and immobilized on a 4‐carboxy‐3‐fluorophenylboronic acid‐immobilized substrate by cyclic diester formation between AFP glycans in an oriented immobilization manner, facilitating the creation of homogeneous AFP‐imprinted nanocavities. Surface‐initiated controlled/living radical polymerization was performed with a functional monomer, co‐monomer, and crosslinker. The disulfide bonds and cyclic diesters were cleaved to create AFP‐imprinted nanocavities, generating free thiol groups present inside the nanocavities only. A thiol‐reactive fluorescent dye was added to the nanocavities by in‐cavity PIM, yielding signaling AFP‐imprinted nanocavities capable of transducing AFP‐binding events into fluorescence changes. Reference proteins showed little response, while the limit of detection of AFP was 0.27 ng/mL (ca. 3.9 pM) in diluted human serum. Thus, the proposed in‐cavity PIM‐based molecular imprinting technique is effective for ELISA‐relevant, antibody‐free sensing systems for glycoproteins.
- 10 March 2017
- Published by Springer Nature in Microchimica Acta
- Vol. 184 (6) , 1595-1601
Pipette tip biosensors for bacterial double-stranded DNA using bioluminescence induced by zinc finger luciferase
- 10 March 2017
- Published by Springer Nature in Microchimica Acta
- Vol. 184 (6) , 1595-1601
Pipette tip biosensors for bacterial double-stranded DNA using bioluminescence induced by zinc finger luciferase